Global  

What is the Trump-endorsed drug being trialled for UK Covid-19 treatment?

Belfast Telegraph Thursday, 21 May 2020
A global trial involving UK health workers of an anti-malarial drug to test its efficacy against the coronavirus comes after Donald Trump said he had begun taking hydroxychloroquine.
0
shares
ShareTweetSavePostSend
 

Related videos from verified sources

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment [Video]

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now..

Credit: Wochit Entertainment     Duration: 00:35Published
Drug used to help fight severe COVID-19 cases used locally [Video]

Drug used to help fight severe COVID-19 cases used locally

A drug recently credited with saving the lives of COVID-19 patients is being used by local doctors.

Credit: NewsChannel 5 Nashville     Duration: 01:39Published
Return To Sender? Millions Of Hydroxychloroquine Pills Locked In Limbo [Video]

Return To Sender? Millions Of Hydroxychloroquine Pills Locked In Limbo

President Donald Trump once touted hydroxychloroquine as “game changers” in the fight against the novel coronavirus COVID-19. Now, millions of doses of the drug are in limbo after the Food and..

Credit: Wochit     Duration: 00:36Published

Related news from verified sources

EU governments ban malaria drug for COVID-19, trial paused as safety fears grow

European governments moved on Wednesday to halt the use of anti-malaria drug hydroxychloroquine to treat COVID-19 patients, and a second global trial of it was...
Reuters

Codebase Ventures updates on coronavirus trials of hydroxychloroquine, highlighting promising data

Codebase Ventures Inc (CSE:CODE) (OTCQB:BKLLF), which owns a 49% stake in a company developing a transdermal hydroxychloroquine (HCQ) patch, told investors...
Proactive Investors Also reported by •Seattle Times

Hydroxychloroquine trial begins as UK bulk-buys drug taken by Trump as unproven coronavirus protection

British government offers pharmaceutical companies contract to supply millions of tablets in case drug becomes recognised as effective treatment
Independent


Tweets about this